港股異動丨部分蘋果概念股走強 蘋果季度銷售和利潤均超預期
格隆匯7月28日丨部分蘋果概念股走強,富智康集團漲逾5%領漲,比亞迪電子漲逾3%,舜宇雖高開逾6%,現倒跌約4%。蘋果週二公佈的季度銷售和利潤均超出分析師預期,受助於消費者購買5G iPhone高端機型和訂閲服務。在iPhone銷量好於預期的推動下,蘋果總營收達到814.3億美元,躍升36.4%,根據路孚特IBES數據,分析師預期營收為733億美元。每股收益為1.30美元,根據路孚特數據,分析師預期為1.01美元。蘋果最強勁的銷售增長來自中國,截至6月26日的第三財季,蘋果在華銷售猛增58%,至147.6億美元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.